Months after Mark Cuban of the Mark Cuban Cost Plus Drug Company suggested the Biden administration cut its current ties to top traditional pharmacy benefit managers and shift federal health programs to new contracts with PBMs operating under a more transparent business model, bipartisan legislation introduced last Tuesday (July 23) offers a similar solution that would implement a transparent model for pharmacy reimbursement across several federal health programs to combat current PBM practices.